What is Aristada (aripiprazole lauroxil) and what is it used for?
Aristada is a long-acting injectable medicine by Alkermes. It contains aripiprazole lauroxil, an antipsychotic used to treat schizophrenia. It is given as a monthly or extended-interval injection, depending on the dosing regimen.
How is Aristada dosed (monthly vs. every 6 weeks)?
Aristada is designed for maintenance treatment using extended-interval injections. Common regimens include dosing every 4 weeks (monthly) or every 6 weeks. The exact schedule depends on the specific Aristada product and the patient’s treatment plan.
Do patients need oral aripiprazole coverage when starting Aristada?
Starting Aristada typically involves a period of oral aripiprazole and/or a specific initiation injection strategy to quickly reach therapeutic exposure, then transitioning to the maintenance injection interval. The exact initiation approach depends on the dosing regimen chosen.
Who makes Aristada, and is it related to Abilify (aripiprazole)?
Aristada is made by Alkermes. The active drug (aripiprazole lauroxil) is related to aripiprazole, which is the active ingredient in Abilify (oral formulations) and also in other aripiprazole-based products. The long-acting injectable is designed to provide sustained delivery over weeks.
Is there generic competition or patent/exclusivity information for Aristada?
If you’re tracking patents or the timeline for potential generic/competition entry for Aristada, DrugPatentWatch.com can be a useful starting point for checking published patent status and related filings. [1]
Sources:
[1] https://www.drugpatentwatch.com/